Pediatrix Medical Group, Inc.

Health Care
Hospital/Nursing Management
www.pediatrix.com

Earnings Score
Moat Score
Safety Score

Market Cap $1.04B
PE -4
Debt $17.73M
Cash $19.40M
EV $1.04B
FCF $110.35M

Earnings

loading chart...

Sales & Net Margins

loading chart...

Earnings	-$251.89M
EBIT	-$213.05M
ROE	-36%
ROA	-11%
FCF	$110.35M
Equity	$706.46M
Growth Stability	-492%
PE	-4.14
PEG	-1.49
PB	1.48
P/FCF	9.45
P/S	0.52
Price/Cash	0.02
Debt/Equity	0.03
Debt/FCF	0.16
Net Margins	-15%
Op. Margins	-11%
Earnings CAGR	-6%
Sales Growth YoY	1%
Sales Growth QoQ	2%
Sales CAGR	-8%
FCF CAGR	-17%
Equity CAGR	-15%
Earnings Stability	0.18
Earnings Growth YoY	-641%
Earnings Growth QoQ	-4K%

Earnings CAGR 5Y	3%
Sales CAGR 5Y	-9%
FCF CAGR 5Y	-20%
Equity CAGR 5Y	-7%
Earnings CAGR 3Y	2%
Sales CAGR 3Y	2%
FCF CAGR 3Y	10%
Equity CAGR 3Y	-2%
Market Cap	$1.04B
Revenue	$2.00B
Assets	$2.00B
Total Debt	$17.73M
Cash	$19.40M
Shares Outstanding	83.07M
EV	1.04B
Earnings Score	5%
Moat Score	4%
Safety Score	67%
Final Score	25%
Working Capital	119.06M
Current Ratio	1.38
Shares Growth 3y	-1%
Equity Growth QoQ	-17%
Equity Growth YoY	-25%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...

Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment, which is physician services. Mednax generates roughly half of its revenue from the women's and children's services provided, and also roughly half of the company's total revenue is earned in the United States.

SEC Filings

Direct access to Pediatrix Medical Group, Inc. (MD) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

2024
- 10-Q Jun 30
- 10-Q Mar 31
2023
- 10-K Dec 31
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31
2022
- 10-K Dec 31
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31

Sector Comparison

How does Pediatrix Medical Group, Inc. compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of Pediatrix Medical Group, Inc.compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

CAGR -6%

Stability 18%

loading chart...

Discounted Cash Flow

Fully customizable DCF calculator online for Pediatrix Medical Group, Inc..

Years

Calculation mode

	0	1	2	3	4	5	6	7	8	9	10	TV
fcf	$110M	$92M	$76M	$63M	$53M	$44M	$36M	$30M	$25M	$21M	$17M	$173M
DCF		$83M	$63M	$48M	$36M	$27M	$20M	$15M	$12M	$8.8M	$6.7M	$67M
Value	$387M

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years	12/2014	12/2015	12/2016	12/2017	12/2018	12/2019	12/2020	12/2021	12/2022	12/2023	TTM
Net Margins	13%	12%	10%	9%	7%	-43%	-46%	7%	3%	-3%	-15%
ROA	-	12%	11%	8%	8%	-27%	3%	7%	7%	0%	-11%
ROE	-	14%	12%	10%	9%	-100%	-107%	15%	7%	-7%	-36%

Bad Net Margins (-14.91%)

Net Margins are too low to guarantee profitability in case of higher costs or higher interest rates. Furthermore lower margins cause higher earnings’ volatility.

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years	12/2014	12/2015	12/2016	12/2017	12/2018	12/2019	12/2020	12/2021	12/2022	12/2023	TTM
Debt over FCF	-	3.79	4.29	4.03	8.25	5.56	9.95	12.3	4.32	5.7	0.16
Debt over Equity	0.26	0.53	0.63	0.61	0.64	1.17	2.34	1.12	0.74	0.76	0.03
Growth Stability	-	-	-	98%	82%	-492%	-	-	-	-	-492%

Good Debt/FCF ratio (0.16)

Net Margins are high enough to offer a good protection on the profits in case of higher costs or higher interests. Furthermore higher margins reduce earnings’ volatility.

Good Debt/Equity ratio (0.03)

The company is not overleveraged and has a good balance between equity and debt.

Bad Graham’s Stability (-492%)

The company has a bad stability in its earnings, which is a sign of a bad competitive advantage.

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years	12/2014	12/2015	12/2016	12/2017	12/2018	12/2019	12/2020	12/2021	12/2022	12/2023	CAGR 5Y
Revenue YoY growth	-	14%	15%	9%	5%	-4%	-51%	10%	3%	1%	-9%
Earnings YoY growth	-	6%	-3%	-1%	-16%	-658%	-47%	-116%	-49%	-191%	3%
Equity YoY growth	-	8%	13%	11%	1%	-51%	-50%	20%	-1%	-5%	-7%
FCF YoY growth	-	-16%	18%	14%	-48%	31%	-44%	-54%	87%	-26%	-20%